Abstract
Two RP-HPLC methods were developed, optimized, and validated for the determination of two different anti-hypertensive combinations in the presence of their degradation products or impurities and in their pharmaceutical formulations. The first mixture is Ramipril (RAM) in combination with Amlodipine besylate (AML) [mixture I], while the second one is a combination of Ramipril (RAM), Atorvastatin (ATV), and Aspirin (ASP) [mixture II].The proposed combinations were successfully separated on X-bridge C18column (250 × 4.6 mm i.d, 5 µm p.s.), using a mobile phase of 0.05 M phosphate buffer-acetonitrile-THF (60:40:0.1% by volume) pH 2.5 and an isocratic mobile phase formed of acetonitrile-0.05 M phosphate buffer-THF (60:40:0.1% by volume) pH 2.5 for mixture (I) and (II) at a flow rate of 1 mL/min and 1.2 mL/min, respectively. The compromising components of the mixtures were detected at 218 nm. For the best separation of the mentioned components different parameters were examined and optimized. The two suggested methods were validated in compliance with the ICH guidelines and were successfully applied for the quantification of the cited components in presence of their obtained degradation products as well as in their commercial pharmaceutical formulations. For both methods the obtained results were statistically analyzed and compared to those of the official and reported methods; using Student’s t test and F test showing no significant difference with high accuracy and good precision.
Similar content being viewed by others
References
Aschar GD, Oliveira L, Cesar P, Rosa P (2015) The degradations routes of Ramipril and its products. Am J Pharmatech Res 5(2):81–94
Babu KA, Kumar GV, Sivasubramanian L (2011) Simultaneous estimation of ramipril and amlodipine in bulk and tablet dosage form by RP-HPLC method. Int J Pharm Pharm Sci 3(4):196–198
British Pharmacopoeia, Medicines and Healthcare Products Regulatory Agency (MHRA), London 2013
Brunton LL, Lazo JS, Parker KL (2006) Goodman & Gilman’s the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York
Dai SY, Qiu ST, Wu W, Fu CM (2013) Development and validation of an rp-hplc method for simultaneous determination of Ramipril and Amlodipine in tablets. J Pharm Anal 3(6):440–446. https://doi.org/10.1155/2014/874587
Darwish HW, Hassan SA, Salem MY, El-Zeany BA (2016) Advanced stability indicating chemometric methods for quantitation of amlodipine and atorvastatin in their quinary mixture with acidic degradation products. Spectrochimica Acta—Part A: Mol Biomol Spectrosc 154:58–66. https://doi.org/10.1016/j.saa.2015.10.007
De Diego M, Godoy G, Mennickent S, Olivares M, Godoy R (2010) Stress degradation studies of ramipril by a validated stability-indicating liquid chromatographic method. J Chil Chem Soc 55(4):450–453. https://doi.org/10.4067/S0717-97072010000400008
Elshanawane AA, Mostafa SM, Elgawish MS (2008) Application of a validated, stability-indicating LC method to stress degradation studies of Ramipril and Moexipril. HCl Chromatographia 67(7/8):567–573. https://doi.org/10.1365/s10337-008-0544-3
Evoy GKM (2009) AHFS Drug Information, American Society of Health-System Pharmacists, Bethesda, pp 2016–2019
Gajula R, Pilli NR, Ravi VB, Maddela R, Inamadugu JK, Polagani SR, Busa S (2012) Simultaneous determination of atorvastatin and aspirin in human plasma by LC-MS/MS: its pharmacokinetic application. Sci Pharm 80(4):923–940. https://doi.org/10.3797/scipharm.1206-12
Gupta KR, Wankhede SB, Tajne MR, Wadodkar SG (2007) Simultaneous determination of Amlodipine and Ramipril by high performance thin layer chromatography. Asian J Chem 19(6):4177–4182
Hassan SA, Elzanfaly ES, Salem MY, ElZeany AB (2016) Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets. Acta Parm 66:479–490. https://doi.org/10.1515/acph-2016-0040
ICH, Q1A (R2) (2003) Stability testing of new drug substances and products. International Conference on Harmonization, IFPMA, Geneva, Switzerland
Kumar AM, Kumar PV, Nasare M, Rao V, Parasad VVL, Diwan VP (2012) Isocratic RP-HPLC estimation of Ramipril and Amlodipine in pharmaceutical dosage form. J Adv Pharm Educ Res 2(3):137–145
Martindale (2003) The complete drug reference; Pharmaceutical Press: London, 33rd edition. 966
Maste MM, Kalekar MC, Kadian N, Bhat AR (2011) Development and validation of RP-HPLC method for simultaneous estimation of Amlodipine and Ramipril in bulk and tablet dosage form. Asian J Res Chem 4(8):1210–1213
Moffat AC, Osselton MD, Widdop B (2011) Clarke’s analysis of drugs and poisons. Pharmaceutical Press, London
Panchal HJ, Suhagia BN, Patel NJ, Rathod IS, Patel BH (2009) Simultaneous estimation of Atorvastatin Calcium, Ramipril and Aspirin in capsule dosage form by RP-LC. Chromatographia 69(1–2):91–95. https://doi.org/10.1365/s10337-008-0831-z
Patel J, Patel M (2014) RP-HPLC method development and validation for the simultaneous estimation of ramipril and amlodipine besylate in capsule dosage form. J Chem Pharm Res 6(6):725–733
Patil PR, Rakesh SU, Dhabale PN, Burade KB (2009) Simultaneous estimation of ramipril and amlodipine by UV spectrophotometric method. Res J Pharm Technol 2(2):304–307. http://www.indianjournals.com/ijor.aspx?target=ijor:rjpt&volume=2&issue=2&article=017
Patole SM, Khodke AS, Potale LV, Damle MC (2010) A validated HPLC method for analysis of atorvastatin calcium, ramipril and asprin as the bulk drug and in combined capsule dosage forms. Int J Pharm Sci Rev Res 4(3):40–45. www.globalresearchonline.net
Rajput PS, Kaur A, Gill NK, Mittal K, Sarma GS (2012) Simultaneous estimation of ramipril and amlodipine in bulk and tablet dosage form by RP-HPLC method. J Appl Pharm Sci 2(7):160–165. https://doi.org/10.7324/japs.2012.2724
Ramadevi K, Saraswathi Z, Maniklal D (2013) RP-HPLC method development for simultaneous determination of the drugs Ramipril and Amlodipine. IJSR 2(2):4–7. https://doi.org/10.15373/22778179/FEB2013/123
Sankar ASK, Vetrichelvan T, Venkappaya D, Nagavalli D (2011) Simultaneous estimation of Ramipril, Aspirin and Atorvastatin Calcium by classical least squares regression in capsule dosage form. Res J Pharm Technol 4(3):398–401. https://www.researchgate.net/publication/286696813_Simultaneous_estimation_of_ramipril_aspirin_and_atorvastatin_calcium_by_classical_least_squares_regression_in_capsule_dosage_form
Sankar ASK, Vetrichelvan T, Venkappaya D (2011b) Simultaneous estimation of ramipril, acetylsalicylic acid and atorvastatin calcium by chemometrics assisted UV-spectrophotometric method in capsules. Acta Pharmaceutica 61(3):283–296. https://doi.org/10.2478/v10007-011-0027-1
Sharma R, Khanna S, Mishra GP (2012) Development and validation of RP-HPLC method for simultaneous estimation of Ramipril, aspirin and Atorvastatin in pharmaceutical preparations. E-J Chem 9(4):2177–2184. https://doi.org/10.1155/2012/891695
Shetty SK, Surendranath KV, Radhakrishnanand P, Borkar RM, Devrukhakar PS, Jogul J, Tripathi UM (2011) Stress degradation behavior of a polypill and development of stability indicating UHPLC method for the simultaneous estimation of aspirin, atorvastatin, ramipril and metoprolol succinate. Am J Anal Chem 2:401–410. https://doi.org/10.4236/ajac.2011.24049
Snyder LR, Kirkland JJ, Dolan JW (2011) Introduction to liquid chromatography, 3rd edn. Wiley, London
United States Pharmacopeia (2007) 30th edition. U.S. Pharmacopeial Convention Rockville, MD
The Merck index, An encyclopedia of chemicals, drugs and biological, 13th Merck Research
Zaazaa HE, Abbas SS, Essam HAM, El-bardicy MG (2012) Validated chromatographic methods for determination of perindopril and amlodipine in pharmaceutical formulation in the presence of their degradation products. J Chromatogr Aphic Sci 51:533–543. https://doi.org/10.1093/chromsci/bms171
Zoglio MA, Maulding HV, Haller RM, Briggen S (1986) Inhibition of stearate lubricant induced degradation of aspirin by the use of certain organic acids. J Pharm Sci 57:1877–1880. https://doi.org/10.1002/jps.2600720914
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors working in this manuscript have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Samy Mostafa, N., AbdElHamid, G., Elsayed Zaazaa, H. et al. Two validated stability-indicating chromatographic methods for the separation of two anti-hypertensive combinations in the presence of their degradation products or impurities. Chem. Pap. 73, 2427–2439 (2019). https://doi.org/10.1007/s11696-019-00792-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11696-019-00792-z